• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRCA 基因突变携带者的临床和器械监测及预防性手术的满意度和对生活质量的影响。

Satisfaction and Impact on Quality of Life of Clinical and Instrumental Surveillance and Prophylactic Surgery in BRCA-mutation Carriers.

机构信息

Obstetrics and Gynaecology Unit, Umberto I Hospital, University of Turin, Italy.

Gynaecology and Obstetrics I, Department of Surgical Sciences, Sant'Anna Hospital, University of Turin, Italy.

出版信息

Clin Breast Cancer. 2018 Dec;18(6):e1361-e1366. doi: 10.1016/j.clbc.2018.07.015. Epub 2018 Jul 26.

DOI:10.1016/j.clbc.2018.07.015
PMID:30122348
Abstract

INTRODUCTION

BRCA 1 and 2 mutation carriers are invited to follow intensive clinical and instrumental surveillance programs or are offered prophylactic breast and ovarian surgery. These recommendations impact many aspects of their life. This study aims to evaluate the satisfaction with surveillance and prophylactic surgery and the impact of these procedures on the quality of life.

PATIENTS AND METHODS

An anonymous questionnaire was administered to 174 BRCA1-2 mutation carriers.

RESULTS

A total of 95% of women comply with the scheduled checks every 6 months. Periodic examinations are considered useful for early diagnosis of breast/ovarian cancer by 91.5% of responders. Among those women who received prophylactic breast surgery, 95% believe that this procedure can reduce cancer risk, but only 65% were completely satisfied by the cosmetic outcome. Among women who underwent prophylactic ovarian surgery, 90.5% would choose it again, mainly owing to a lower degree of concern about ovarian cancer risk. The early onset of menopausal symptoms was the most frequently reported side effects, but only 21% of patients use any treatment to relieve them.

CONCLUSION

Women who follow a surveillance program show a good level of satisfaction, thanks to the lowering of concerns of cancer risk. The degree of satisfaction about the prophylactic surgery is generally high. Risk-reducing mastectomy is usually well-accepted, despite the fact that cosmetic results are not entirely satisfactory. Bilateral salpingo-oophorectomy may impact on quality of life because of the symptoms associated with early surgical menopause, even if it can be treated with hormonal replacement therapies.

摘要

简介

BRCA1 和 BRCA2 基因突变携带者被邀请参加强化临床和仪器监测计划,或接受预防性乳房和卵巢手术。这些建议会影响他们生活的许多方面。本研究旨在评估对监测和预防性手术的满意度,以及这些手术对生活质量的影响。

患者和方法

对 174 名 BRCA1-2 基因突变携带者进行了匿名问卷调查。

结果

共有 95%的女性每 6 个月按时进行计划检查。91.5%的应答者认为定期检查有助于早期诊断乳腺癌/卵巢癌。在接受预防性乳房手术的女性中,95%的人认为该手术可以降低患癌风险,但只有 65%的人对美容效果完全满意。在接受预防性卵巢手术的女性中,90.5%的人会再次选择这种手术,主要是因为对卵巢癌风险的担忧程度降低。绝经症状提前是最常报告的副作用,但只有 21%的患者使用任何治疗方法来缓解这些症状。

结论

参加监测计划的女性满意度较高,这要归功于降低了对癌症风险的担忧。预防性手术的满意度普遍较高。尽管美容效果并不完全令人满意,但降低风险的乳房切除术通常被广泛接受。双侧输卵管卵巢切除术可能会因与早期手术性绝经相关的症状而影响生活质量,尽管可以用激素替代疗法治疗。

相似文献

1
Satisfaction and Impact on Quality of Life of Clinical and Instrumental Surveillance and Prophylactic Surgery in BRCA-mutation Carriers.BRCA 基因突变携带者的临床和器械监测及预防性手术的满意度和对生活质量的影响。
Clin Breast Cancer. 2018 Dec;18(6):e1361-e1366. doi: 10.1016/j.clbc.2018.07.015. Epub 2018 Jul 26.
2
Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.BRCA 突变携带者的双侧预防性乳房切除术:外科医生需要了解的内容。
Ann Ital Chir. 2019;90:1-2.
3
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.接受BRCA1和BRCA2检测的女性临床特征与风险降低干预措施之间的关联:一项单机构研究。
Cancer. 2006 Dec 15;107(12):2745-51. doi: 10.1002/cncr.22352.
4
Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study.预防性降低风险的输卵管卵巢切除术在 BRCA 基因突变携带者中的满意度非常高,且与手术时患者的特征相关性很小:一项前瞻性研究。
Menopause. 2021 Feb 1;28(3):263-270. doi: 10.1097/GME.0000000000001737.
5
A simulation model to predict the impact of prophylactic surgery and screening on the life expectancy of BRCA1 and BRCA2 mutation carriers.用于预测预防性手术和筛查对 BRCA1 和 BRCA2 突变携带者预期寿命影响的仿真模型。
Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1066-77. doi: 10.1158/1055-9965.EPI-12-0149. Epub 2012 May 3.
6
Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers.BRCA1/2 基因突变携带者的监测和预防策略的成本效益分析。
Breast Cancer. 2018 Mar;25(2):141-150. doi: 10.1007/s12282-017-0803-y. Epub 2017 Oct 10.
7
Prophylactic mastectomy with immediate reconstruction combined with simultaneous laparoscopic salpingo-oophorectomy via a transmammary route: a novel surgical approach to female BRCA-mutation carriers.经乳腺途径行预防性乳房切除术并即刻重建联合同期腹腔镜输卵管卵巢切除术:一种针对女性 BRCA 突变携带者的新型手术方法。
Arch Gynecol Obstet. 2014 Jun;289(6):1325-30. doi: 10.1007/s00404-013-3133-0. Epub 2014 Jan 4.
8
Hormone therapy after prophylactic risk-reducing bilateral salpingo-oophorectomy in women who have BRCA gene mutation.携带BRCA基因突变的女性在进行预防性双侧输卵管卵巢切除术后的激素治疗。
Climacteric. 2016 Oct;19(5):419-22. doi: 10.1080/13697137.2016.1209396. Epub 2016 Jul 16.
9
[Satisfaction and overall quality of life in BRCA positive women after prophylactic surgeries].[BRCA基因阳性女性预防性手术后的满意度及总体生活质量]
Rozhl Chir. 2017 Fall;96(8):328-333.
10
Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer.BRCA 基因突变携带者伴卵巢癌病史行预防性乳房切除术与监测的成本效果比较。
Ann Surg Oncol. 2017 Oct;24(11):3116-3123. doi: 10.1245/s10434-017-5995-z. Epub 2017 Jul 11.

引用本文的文献

1
Treatment Patterns, Clinical Outcomes and Quality of Life in BRCA1/2-Associated Breast Cancer Patients: A Retrospective Analysis.BRCA1/2相关乳腺癌患者的治疗模式、临床结局及生活质量:一项回顾性分析
Curr Oncol. 2025 May 2;32(5):269. doi: 10.3390/curroncol32050269.
2
Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers.BRCA1的三十年:机制洞察及其对突变携带者的影响
Cancer Discov. 2025 Mar 3;15(3):461-480. doi: 10.1158/2159-8290.CD-24-1326.
3
Fear of cancer recurrence in breast cancer survivors carrying a BRCA1 or 2 genetic mutation : a cross-sectional study.
携带BRCA1或2基因突变的乳腺癌幸存者对癌症复发的恐惧:一项横断面研究。
Hered Cancer Clin Pract. 2024 Aug 27;22(1):16. doi: 10.1186/s13053-024-00285-5.
4
Prophylactic Interventions for Hereditary Breast and Ovarian Cancer Risks and Mortality in BRCA1/2 Carriers.BRCA1/2基因携带者遗传性乳腺癌和卵巢癌风险及死亡率的预防性干预措施
Cancers (Basel). 2023 Dec 24;16(1):103. doi: 10.3390/cancers16010103.
5
Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial.基于证据的决策辅助工具在德国医疗保健环境中对携带致病性 BRCA1 或 BRCA2 变异的女性的有效性:一项随机对照试验的结果。
BMC Med Inform Decis Mak. 2023 Oct 16;23(1):223. doi: 10.1186/s12911-023-02327-9.
6
Surgical Decision Making in Genetically High-Risk Women: Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy.遗传高风险女性的手术决策:降低风险乳房切除术术后补充手术的术后并发症和长期风险的量化。
Ann Surg Oncol. 2024 Jan;31(1):356-364. doi: 10.1245/s10434-023-14418-y. Epub 2023 Oct 14.
7
How Does Dietary Intake Relate to Dispositional Optimism and Health-Related Quality of Life in Germline Mutation Carriers?饮食摄入与种系突变携带者的性格乐观和健康相关生活质量有何关系?
Nutrients. 2023 Mar 14;15(6):1396. doi: 10.3390/nu15061396.
8
Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in Carriers: A Systematic Review and Meta-Analysis.携带者行降低风险的输卵管卵巢切除术后的乳腺癌风险及乳腺癌特异性死亡率:一项系统评价和荟萃分析
Cancers (Basel). 2023 Mar 6;15(5):1625. doi: 10.3390/cancers15051625.
9
Long-Term Non-Cancer Risks in People with Mutations following Risk-Reducing Bilateral Salpingo-Oophorectomy and the Role of Hormone Replacement Therapy: A Review.双侧输卵管卵巢切除术后突变人群的长期非癌症风险及激素替代疗法的作用:综述
Cancers (Basel). 2023 Jan 24;15(3):711. doi: 10.3390/cancers15030711.
10
Management Strategies of Breast Cancer Patients with and Pathogenic Germline Variants.携带致病性胚系变异的乳腺癌患者的管理策略
Onco Targets Ther. 2022 Jul 27;15:815-826. doi: 10.2147/OTT.S369844. eCollection 2022.